Traws Pharma
TRAW
TRAW
19 hedge funds and large institutions have $3.98M invested in Traws Pharma in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
19
Holders Change
–
Holders Change %
0%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
8
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
![]()
Adage Capital Partners
Boston,
Massachusetts
|
+$759K |
2 |
PA
Perceptive Advisors
New York
|
+$593K |
3 |
VPC
Vestal Point Capital
New York
|
+$230K |
4 |
UBS Group
Zurich,
Switzerland
|
+$31.1K |
5 |
Geode Capital Management
Boston,
Massachusetts
|
+$28.9K |
Top Sellers
1 |
IC
Ikarian Capital
Dallas,
Texas
|
-$161K |
2 |
![]()
Alyeska Investment Group
Chicago,
Illinois
|
-$147K |
3 |
Renaissance Technologies
New York
|
-$89.3K |
4 |
Morgan Stanley
New York
|
-$34.5K |
5 |
![]()
Group One Trading
Chicago,
Illinois
|
-$10.3K |